TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Quality of interventional activity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MSQoL improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Depression improvement (PHQ-9)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Work productivity improvement (WPAI)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: POSN availability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of baseline questionnaires within 1 week
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Retention rates in the Heart trial
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Response rates to questionnaires after reminders
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean value of 6-minute walking distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion rate of breathing exercise
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Efficacy measured by HDRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete LA avulsion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Izbicki pain score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of nucleic acid turning negative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of nucleic acid turning negative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of clinical symptoms appearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: non-remission
Endpoint domain: Mortality/survival
Primary endpoint: mean PGA improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean IGA improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroconversion rates of anti-HBs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in shoulder function (WOSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in shoulder function (DASH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in shoulder function (PSFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal extraction of GLP-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Residual limb pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional assessment (OPUS Rasch scores)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Consultation with healthcare professionals regarding LUTS
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Femoral spike distance ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of motion surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Propofol EC50
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Limited visualization of the abdominal aorta
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Refracture rate
Endpoint domain: Adverse events/effects
Primary endpoint: lifetime risk of cervical cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: cost per year of life saved (YLS)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Psychological distress (PSS scores)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ADHD-5-RS total score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responder rate based on CGI-I
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in false-positive diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in number of biopsies
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Postoperative VAS for pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: serrated lesion detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: polyp miss rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of patients with one or more BS
Endpoint domain: Adverse events/effects
Primary endpoint: Relative risk of BS in IG patients
Endpoint domain: Adverse events/effects
Primary endpoint: Score of the modified Young scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistent patellar instability at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TNF‐α to IL‐10 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IL‐6 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IL‐1β concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Bothersome de novo SUI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: De novo dyspareunia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality due to variceal bleeding and sepsis
Endpoint domain: Mortality/survival
Primary endpoint: Bacterial peritonitis and infection rates
Endpoint domain: Adverse events/effects
Primary endpoint: safety of accelerated antibiotic therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Virologic suppression rates (HIV RNA < 400 copies/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time being sedentary
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LPA (Light Physical Activity) time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MVPA (Moderate to Vigorous Physical Activity) time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient preference for DEX over PRED therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Risk of neuroticism
Endpoint domain: Mortality/survival
Primary endpoint: Propofol usage during sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Episodes of deep sedation
Endpoint domain: Adverse events/effects
Primary endpoint: Time to discharge from PACU
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: being pain-free at 2 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of infected premises (IP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: outbreak duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean CCQ total score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: First attempt success rate of lumbar epidural catheterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-operative morbidity rate
Endpoint domain: Adverse events/effects
Primary endpoint: mania symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost per unit score improvement in anxiety and depression symptoms
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incremental cost-effectiveness ratio (ICER) for treating depression
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Post-exercise recovery
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: performance in timed-up-and-go
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to all-cause hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: median time to OHE resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average pain intensity in the previous 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average pain intensity in the previous week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful food reintroduction
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: mean total CPD at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fagerström Test of Nicotine Dependence mean total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Empathic communication
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cost of hypoxemia treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Negative conversion rate of SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Duration of clinical recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of coaches providing alignment cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of full NMT program by coaches
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: vocal effort ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients refusing advice
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean cost for patients who refused
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Extensive pathological treatment response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of wound complication requiring intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Correct details recalled
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality due to COVID-19 complications
Endpoint domain: Mortality/survival
Primary endpoint: severe hypoxemia during intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Thermal pain sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: statistically significant difference in the primary outcome favoring the experimental intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Management of Type 2 Diabetes (T2D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement with subspecialists
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: visit-to-visit systolic BPV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recovery from mucormycosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New-onset post-COVID hyperglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in PBVC from baseline to week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of new T2 brain lesions at week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: SERT-enriched response to faces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: IL‐1β mRNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Center of Pressure (COP) changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRST scores for postural tremor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Combined hand tremor/motor scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Functional disability scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: tcMEP intensity at the end of surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical status score at day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: children's emotional and behavioral difficulties
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: health services utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement of surgical skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: mean bacteria count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical activity change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of severe diarrhea (Vesikari score ≥ 11)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Diarrhea requiring hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: WSL size reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IOD ratio reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ΔE improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscular injury
Endpoint domain: Adverse events/effects
Primary endpoint: ease-of-use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cognitive ergonomics
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: birthweight z score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neonatal body fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SGA (small for gestational age)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Access to a basic nutritious diet
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: rate of hip fracture surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: FT4 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: subclinical or overt thyrotoxicosis
Endpoint domain: Adverse events/effects
Primary endpoint: Exclusive Breastfeeding (EBF) rates at 1 month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exclusive Breastfeeding (EBF) rates at 5 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of early coagulopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Improvement in self-assessed self-efficacy on AF ablation knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient satisfaction with preprocedural education and materials
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preparedness for AF catheter ablation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cervical morbidity and mortality
Endpoint domain: Mortality/survival
Primary endpoint: Overall operation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Speed (g/min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: UKPDS risk score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 1-year neurodevelopmental quotient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: SCT scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of cardiovascular event
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of days meeting step goal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital revisit within six months of discharge
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: screen time reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: improved attention score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Median total blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Intraoperative bleeding rate
Endpoint domain: Adverse events/effects
Primary endpoint: Mortality at day 180
Endpoint domain: Mortality/survival
Primary endpoint: Time to liberation from respiratory support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported six-month general functionality
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: overall histologic improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in steatosis grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drain removal time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Personnel Satisfaction Assessment score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Accuracy of diagnosis of CAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean dose of opioids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time of first request for analgesic medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median VAS score on mobilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insomnia Daytime Symptoms and Impacts Questionnaire total scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Mean PIF rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Inspiratory volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of delirium within seven days of admission
Endpoint domain: Mortality/survival
Primary endpoint: self-reported symptoms of central sensitization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain cognitions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of crossover events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postprandial blood sugar (PPBS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Transitions in weight status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of problem-solving development delay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of gross motor delay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms of depression and anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliable recovery rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 3-year recurrence-free survival (RFS) rate
Endpoint domain: Mortality/survival
Primary endpoint: postprandial response of FGF19
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postprandial response of C4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fracture strength of crowns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breastfeeding initiation success
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nipple length improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: whole-body lean mass (LM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: appendicular lean mass (LM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: whole-body fat percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: earlier diagnosis of DVT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: earlier diagnosis of PE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical inactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 2+ GI toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: EPIC bowel QoL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: PSA failure rate
Endpoint domain: Mortality/survival
Primary endpoint: Objective treatment knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean change in hemoglobin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Higher order aberration (HOA) root mean square (RMS) repeatability limit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: umbilical arterial HCO3−
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: base excess (BE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: lactate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes